Facilitating the research of numerous nationally and internationally recognized scientists, in over sixty labs across British Columbia, to improve cancer care.

BC Cancer Research strives to improve the lives of patients through the integration of basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the development of innovative new technology, programs, and interventions. Organized through departments and programs with various themes, BC Cancer supports groundbreaking cancer research and personalized care approaches through world-class facilities and platforms including genomics, bioinformatics, imaging, drug development and tissue banking.

Our Research

At BC Cancer, collaboration is at the root of every discovery and breakthrough that impacts patient care. Our 2024 Research Report showcases the many achievements at BC Cancer that were a result of our priority to integrate research and cancer care, and continue collaborations with local, national and international partners.

Read the 2024 BC Cancer Research Report

News & Events

Research Recovery Resources

BC Cancer Research is taking a gradual and careful approach to re-opening research activities to protect our staff, patients and communities.

Access our COVID-19 recovery resources.

Our Strategic Plan

Our Strategic Plan outlines our direction to strengthen our research capabilities and collaboration with departments and partners to improve our ability to generate knowledge, enhance the impact of our research, and support innovation in clinical care.  

Read the BC Cancer Research Strategic Plan.

Facilitating research excellence through management of day-to-day operations.

Office of Research Administration

Conducting research to improve the prevention, detection and treatment of cancer.

Population Health Sciences

Making novel discoveries in the biology underlying normal development and cancer progression.

Terry Fox Laboratory

Characterising the molecular changes that underpin the progression and pathogenesis of cancer.

Molecular Oncology

Researching the optical, radiobiological and genetic properties of cancer.

Integrative Oncology

Improving patient outcomes by gaining a deeper understanding of lymphoma biology and progression, for use in clinical applications.

Lymphoid Cancer Research

Defining better intervention strategies for individuals diagnosed with aggressive cancers.

Experimental Therapeutics

Clinical Research

Harnessing the immune system to detect and treat cancer.

Deeley Research Centre

The Nursing Research department promotes innovation and excellence in interprofessional research and knowledge mobilization to drive evidence-informed improvements in care, better patient outcomes and increased system performance.

Nursing Research

Basic & Translational Research

Publications

Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.

medRxiv [Preprint]. 2025
Lin YY, Noghabi HS, Volik S, Bell R, Sar F, Haegert A, Chung HC, Fazli L, Oo HZ, Daugaard M, Kuo MH, Hsu SC, Imeda EL, Zanettini C, Queiroz L, Schlotmann B, Gheybi K, Cooper C, Kote-Jarai Z, Eeles R; Pan Prostate Cancer Group (PPCG); Kung HJ, Marchionni L, Weischenfeldt J, Miller KD, Rabinowitz A, Wang Y, Zhang HF, Sorensen PH, Carey MS, Gleave M, Hayes VM, Gibson WT, Collins CC.
Learn More

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.

Blood Cancer Discov. 2025
Thomas N, García-Prieto CA, Dreval K, Hilton LK, Abramson JS, Bartlett NL, Bethony J, Bowen J, Bryan AC, Casper C, Dyer MA, Gastier-Foster JM, Gerrie AS, Greiner TC, Griner NB, Gross TG, Harris N, Irvin JD, Jaffe ES, Leal FE, Mbulaiteye SM, Mullighan CG, Mungall AJ, Mungall KL, Namirembe C, Noy A, Ogwang MD, Orem J, Ott G, Petrello H, Reynolds SJ, Swerdlow SH, Traverse-Glehen A, Wilson WH, Marra MA, Staudt LM, Scott DW, Esteller M, Morin RD.
Learn More
Back to top